0001209191-22-042688.txt : 20220720 0001209191-22-042688.hdr.sgml : 20220720 20220720163606 ACCESSION NUMBER: 0001209191-22-042688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220718 FILED AS OF DATE: 20220720 DATE AS OF CHANGE: 20220720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marek David C CENTRAL INDEX KEY: 0001556914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37929 FILM NUMBER: 221094611 MAIL ADDRESS: STREET 1: C/O WEBMD HEALTH CORP. STREET 2: 111 EIGHTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Myovant Sciences Ltd. CENTRAL INDEX KEY: 0001679082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB BUSINESS PHONE: 44 207-400-3351 MAIL ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-18 0 0001679082 Myovant Sciences Ltd. MYOV 0001556914 Marek David C C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005 1 1 0 0 Principal Executive Officer Common Shares 2022-07-18 4 S 0 11164 12.87 D 436792 D Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. /s/ Matthew Lang, Attorney-in-fact 2022-07-20